HOME >> BIOLOGY >> NEWS
Costly tests unnecessary for some miscarriages, University of Pittsburgh geneticist says

ies, and one in five pregnancies end in miscarriage, many second and third miscarriages are likely to be simply by chance alone. In addition, other studies have shown that these couples have a 70 percent chance of having a successful subsequent pregnancy," said Dr. Hogge. "If there is a chromosomal abnormality, there's no reason to do more extensive and expensive testing."

Dr. Hogge and his colleagues recommend that karyotyping tests be pursued regularly after the second loss, with more advanced diagnostic tests ordered for both parents only when no genetic abnormality is found. "Having an explanation for the loss often removes significant guilt regarding whether the couple 'did something wrong to cause the miscarriage,' " he said.


'"/>

Contact: Michele Baum
412-647-3555
University of Pittsburgh Medical Center
27-Jan-2003


Page: 1 2

Related biology news :

1. Carnegie Mellon researcher tests tools for protecting Anacostia River ecosystem from PCBs
2. DNA tests point to extinction of 2 distinctive arctic bird populations
3. FSU scientists develop new tests to detect nut allergens in processed food
4. Only 21 states offer newborn screening tests recommended by March of Dimes
5. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
6. Uncertainty in clinical tests raises health care costs
7. Research to create lung-cancer blood tests receives $3.4M in Pennsylvania tobacco settlement funds
8. Current smoke alarms pass life-saving tests
9. Why results from genetic tests should be available to medical insurance companies
10. AGI announces the winners of Earth Science Week 2003 contests
11. Lab tests can reveal how patients respond to Gleevec

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):
(Date:9/15/2017)... ... September 15, 2017 , ... ... what it calls an ‘Internal Seed B’ round of financing, totaling $600,000. ... was completed using a ‘SAFE’ documentation structure at a company valuation of $10M. ...
(Date:9/14/2017)... ... September 14, 2017 , ... ... CliniControl™ (CC) product portfolio, clinically-relevant starting and ancillary materials that generate unprecedented ... Stem/Stromal Cell (hMSC)-based therapies. The CliniControl product portfolio will radically simplify major ...
(Date:9/14/2017)... ... 14, 2017 , ... One of the world’s largest World Marrow Donor Day ... hours that day, the GenCure Marrow Donor Program will be signing up potential donors ... in San Antonio. , The registration tables will be staffed by employees from all ...
(Date:9/13/2017)... ... September 13, 2017 , ... AMRI, a global contract ... patient outcomes and quality of life for more than 25 years, today announced ... expert to the International Standards Organization/Technical Committee 194: Biological and Clinical Evaluation ...
Breaking Biology Technology:
Cached News: